Helicobacter pylori treatment: A practical approach

American Journal of Gastroenterology

Volumn 101, Issue 3, 2006, Pages 497-499

  Vakil, Nimish ^a,b  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b AURORA SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; BISMUTH; CLARITHROMYCIN; METRONIDAZOLE; OMEPRAZOLE; PROTON PUMP INHIBITOR; RANITIDINE BISMUTH CITRATE; TETRACYCLINE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; BACTERIAL VIRULENCE; CLINICAL PRACTICE; CLINICAL TRIAL; DIARRHEA; DRUG BIOAVAILABILITY; DRUG FORMULATION; DRUG HALF LIFE; DRUG METABOLISM; ERADICATION THERAPY; GASTRITIS; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; PATIENT COMPLIANCE; PRIORITY JOURNAL; REVIEW; STOMACH MUCOSA; TASTE DISORDER; TREATMENT FAILURE; UREA BREATH TEST;

BISMUTH; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; GASTRITIS; HELICOBACTER INFECTIONS; HUMANS; OFLOXACIN; RANDOMIZED CONTROLLED TRIALS; TREATMENT OUTCOME;

EID: 33644782035     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2006.00454.x     Document Type: Review

References (16)

1. Goddard A Review article: Factors influencing antibiotic transfer across the gastric mucosa Aliment Pharmacol Ther 1998 12 1175 84
2. Erah P Goddard A Barrett D et al. The stability of amoxicillin, clarithromycin and metronidazole in gastric juice: Relevance to the treatment of Helicobacter pylori infection J Antimicrob Chemother 1997 39 5 12
3. Sherwood P Wibawa J Atherton J et al. Impact of acid secretion, gastritis and mucus thickness on gastric transfer of antibiotics in rats Gut 2002 51 490 4
4. Goddard A Jessa M Barrett D et al. Effect of omeprazole on the distribution of metronidazole, amoxicillin and clarithromycin in human gastric juice Gastroenterology 1996 111 358 67
5. Gustavson L Kaiser J Edmonds ALC et al. Effect of omeprazole on gastric concentrations of clarithromycin in plasma and gastric tissue at steady state Antimicrob Agents Chemother 1992 36 1147 50
6. Pedrazzoli J Calafatti S Ortiz R et al. Transfer of clarithromycin to gastric juice is enhanced by omeprazole in Helicobacter pylori-infected individuals Scand J Gastroenterol 2001 36 1248 53
7. Gisbert J Gonzalez L Calvet X Systematic review and meta-analysis: Proton pump inhibitor vs. ranitidine bismuth citrate plus two antibiotics in Helicobacter pylori eradication Helicobacter 2005 10 157 71
8. Duck WM Sobel J Pruckler JM et al. Antimicrobial resistance incidence and risk factors among Helicobacter pylori-infected persons, United States Emerg Infect Dis 2004 10 6 1088 94
9. Vakil N Hahn B McSorley D Clarithromycin-resistant Helicobacter pylori in patients with duodenal ulcer in the United States Am J Gastroenterol 1998 93 9 1432 5
10. Perez Aldana L Kato M Nakagawa S et al. The relationship between consumption of antimicrobial agents and the prevalence of primary Helicobacter pylori resistance Helicobacter 2002 7 306 9
11. Houben M van de Beek D Hensen E et al. A systematic review of helicobacter eradication therapy - the impact of antimicrobial resistance on eradication rates Aliment Pharmacol Ther 1999 13 1047 55
12. Laine L Fennerty MB Osato M et al. Esomeprazole-based Helicobacter pylori eradication therapy and the effect of antibiotic resistance: Results of three US multicenter, double-blind trials Am J Gastroenterol 2000 95 12 3393 8
13. Laine L Hunt R El-Zimaity H et al. Bismuth-based quadruple therapy using a single capsule of bismuth biskalcitrate, metronidazole, and tetracycline given with omeprazole versus omeprazole, amoxicillin, and clarithromycin for eradication of Helicobacter pylori in duodenal ulcer patients: A prospective, randomized, multicenter, North American trial Am J Gastroenterol 2003 98 3 562 7
14. Laine L Suchower L Frantz J et al. Twice-daily, 10-day triple therapy with omeprazole, amoxicillin, and clarithromycin for Helicobacter pylori eradication in duodenal ulcer disease: Results of three multicenter, double-blind, United States trials Am J Gastroenterol 1998 93 11 2106 12
15. Fennerty MB Kovacs TO Krause R et al. A comparison of 10 and 14 days of lansoprazole triple therapy for eradication of Helicobacter pylori Arch Intern Med 1998 158 15 1651 6
16. Bochenek WJ Peters S Fraga PD et al. Helicobacter pylori Pantoprazole Eradication (HELPPE) Study Group. Eradication of Helicobacter pylori by 7-day triple-therapy regimens combining pantoprazole with clarithromycin, metronidazole, or amoxicillin in patients with peptic ulcer disease: Results of two double-blind, randomized studies Helicobacter 2003 8 6 626 42